ALPS Advisors’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-30,878
Closed -$572K 1026
2023
Q3
$572K Buy
30,878
+235
+0.8% +$4.36K ﹤0.01% 581
2023
Q2
$339K Buy
30,643
+3,188
+12% +$35.3K ﹤0.01% 757
2023
Q1
$369K Sell
27,455
-682
-2% -$9.16K ﹤0.01% 659
2022
Q4
$348K Buy
28,137
+11,908
+73% +$147K ﹤0.01% 751
2022
Q3
$226K Sell
16,229
-1,404
-8% -$19.6K ﹤0.01% 987
2022
Q2
$244K Sell
17,633
-12,882
-42% -$178K ﹤0.01% 955
2022
Q1
$496K Sell
30,515
-3,679
-11% -$59.8K 0.01% 434
2021
Q4
$557K Sell
34,194
-6,495
-16% -$106K 0.01% 480
2021
Q3
$604K Sell
40,689
-2,991
-7% -$44.4K 0.01% 478
2021
Q2
$872K Sell
43,680
-16,055
-27% -$321K 0.01% 420
2021
Q1
$1.38M Buy
59,735
+121
+0.2% +$2.79K 0.01% 361
2020
Q4
$1.47M Buy
59,614
+17,557
+42% +$434K 0.02% 351
2020
Q3
$1.74M Sell
42,057
-2,876
-6% -$119K 0.03% 250
2020
Q2
$2.15M Sell
44,933
-14,578
-24% -$699K 0.03% 232
2020
Q1
$3.75M Sell
59,511
-6,437
-10% -$405K 0.06% 162
2019
Q4
$8.17M Buy
+65,948
New +$8.17M 0.06% 127
2018
Q4
Sell
-52,318
Closed -$6.61M 961
2018
Q3
$6.61M Buy
52,318
+9,864
+23% +$1.25M 0.04% 141
2018
Q2
$3.56M Buy
+42,454
New +$3.56M 0.02% 193
2017
Q4
Sell
-24,720
Closed -$1.44M 890
2017
Q3
$1.44M Buy
24,720
+2,147
+10% +$125K 0.01% 212
2017
Q2
$2.73M Buy
22,573
+1,231
+6% +$149K 0.02% 168
2017
Q1
$2.41M Sell
21,342
-2,500
-10% -$283K 0.02% 166
2016
Q4
$2.59M Sell
23,842
-7,679
-24% -$834K 0.02% 165
2016
Q3
$5.19M Sell
31,521
-3,030
-9% -$499K 0.04% 136
2016
Q2
$4.93M Buy
34,551
+7,187
+26% +$1.03M 0.04% 126
2016
Q1
$3.52M Sell
27,364
-4,688
-15% -$602K 0.04% 129
2015
Q4
$4.79M Buy
+32,052
New +$4.79M 0.05% 122